Discovery of Fulzerasib (GFH925) for the Treatment of KRAS G12C-Mutated Solid Tumors.

Jiang T, Lin C, Le S, Zhang L, Liang T, Cai L, Lan X, Ge M, Liu Z, He W, Peng L, Zhao Y, Ren J, Yan F, Lu Q, Lan J, Zhou F

Open source

DOI: 10.1021/acs.jmedchem.4c03183
Published: 2025 Aug 14
Container: Journal of medicinal chemistry
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acs.jmedchem.4c03183,
  title = {Discovery of Fulzerasib (GFH925) for the Treatment of KRAS G12C-Mutated Solid Tumors.},
  author = {Jiang T and Lin C and Le S and Zhang L and Liang T and Cai L and Lan X and Ge M and Liu Z and He W and Peng L and Zhao Y and Ren J and Yan F and Lu Q and Lan J and Zhou F},
  year = {2025},
  journal = {Journal of medicinal chemistry},
  doi = {10.1021/acs.jmedchem.4c03183},
  url = {https://doi.org/10.1021/acs.jmedchem.4c03183}
}

RIS

TY  - JOUR
TI  - Discovery of Fulzerasib (GFH925) for the Treatment of KRAS G12C-Mutated Solid Tumors.
AU  - Jiang T
AU  - Lin C
AU  - Le S
AU  - Zhang L
AU  - Liang T
AU  - Cai L
AU  - Lan X
AU  - Ge M
AU  - Liu Z
AU  - He W
AU  - Peng L
AU  - Zhao Y
AU  - Ren J
AU  - Yan F
AU  - Lu Q
AU  - Lan J
AU  - Zhou F
PY  - 2025
JO  - Journal of medicinal chemistry
DO  - 10.1021/acs.jmedchem.4c03183
UR  - https://doi.org/10.1021/acs.jmedchem.4c03183
ER  -

APA

T, J., C, L., S, L., L, Z., T, L., L, C., X, L., M, G., Z, L., W, H., L, P., Y, Z., J, R., F, Y., Q, L., J, L., & F, Z. (2025). Discovery of Fulzerasib (GFH925) for the Treatment of KRAS G12C-Mutated Solid Tumors.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.4c03183

Source records

pubmed · retrieved 2026-09-26T22:41:00.414Z